Myalgic Encephalomyelitis (ME) or What? An Operational Definition.

Area of Science:

• Neurology
• Immunology
• Infectious Disease

Background:

• Myalgic encephalomyelitis (ME) was identified in 1956 as a distinct neuromuscular disease.
• The introduction of chronic fatigue syndrome (CFS) in 1988 led to ME being overshadowed and misclassified.
• Effective therapies for ME and CFS require specific investigation of ME patients, necessitating a clear operational definition.

Purpose of the Study:

• To propose an operational definition for Myalgic Encephalomyelitis (ME).
• To differentiate ME from other post-viral conditions and chronic fatigue syndrome (CFS).
• To establish criteria for accurate diagnosis and targeted therapeutic development.

Main Methods:

• Review of recent formal definitions and observed symptoms of ME.
• Development of an operational definition based on characteristic ME clinical features.
• Identification of mandatory elements for a discriminative ME definition.

Main Results:

• ME is a multi-systemic illness with varied onset, epidemic/endemic forms, and a unique clinical pattern.
• Key distinguishing features include muscle fatigability/post-exertional weakness, neurological disturbances (cognitive, autonomic, sensory), symptom fluctuation, and a prolonged relapsing course.
• A discriminative definition requires muscle fatigability/post-exertional weakness lasting days, defined neurological disturbance criteria, symptom fluctuation, and a prolonged relapsing course.

Conclusions:

• The proposed operational definition aids in distinguishing ME from CFS and other conditions.
• The identified mandatory elements support classifying ME as a neuromuscular disease.
• Accurate definition is crucial for advancing research and developing effective treatments for ME.